苦瓜胜肽（山苦瓜胜肽 / mcIRBP-19） Bitter Melon Peptide (mcIRBP-19 / MAP30) × 第二型糖尿病
結論：證據分歧
機轉合理（mcIRBP-19 為類胰島素胜肽、結合 insulin receptor 並促 GLUT4 轉位），但人體證據薄弱：對胜肽單離物僅有 Lo HY 2017 一篇小型 RCT（n=42、業界資助、低品質、HbA1c 僅降 0.
B 🟡 B 初步證據 證據分歧 ⚠️ medium — moderate promotional content
機轉合理（mcIRBP-19 為類胰島素胜肽、結合 insulin receptor 並促 GLUT4 轉位），但人體證據薄弱：對胜肽單離物僅有 Lo HY 2017 一篇小型 RCT（n=42、業界資助、低品質、HbA1c 僅降 0.21~0.5% 處臨床顯著性門檻、無獨立複現、無長期/硬終點）。
最高層級證據（Ooi 2012 Cochrane n=479）對整株苦瓜判為證據不足；Yin 2014 MA 之 HbA1c 不顯著。
整株證據與胜肽單離物不可互通。
對應 Tier 錨點『機轉合理 + 少量人體研究；學會 insufficient evidence』，獨立判讀為 C（薄弱證據），非 B。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.56
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 證據分歧
信心度
74%
證據方向大致一致
證據層級
E1
Cochrane 高品質系統性回顧／統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.556
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative)，由 raw_score 決定
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 1 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
A randomized, double-blind, placebo-controlled trial to evaluate the hypoglycemic efficacy of the mcIRBP-19-containing Momordica charantia L. fruit extracts in the type 2 diabetic subjects
結論：Statistically significant reduction in HbA1c of approximately 0.21%-0.5% in the mcIRBP-19 group vs placebo at 12 weeks (p<0.05); FPG also modestly reduced. No serious adverse events. Effect size smaller than pharmaceutical OHAs; sample very small.
前往 PubMed
Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein
結論：mcIRBP-19 binds insulin receptor and lowers blood glucose in STZ-diabetic and db/db mouse models; identifies a 19-aa peptide as a candidate active fraction. Mechanistic/preclinical only; does not establish human efficacy.
前往 PubMed
Momordica charantia for type 2 diabetes mellitus (Cochrane Review)
結論：Insufficient evidence on the effects of M. charantia for T2DM. Two trials of fair methodological quality found no statistically significant difference in HbA1c vs placebo or hypoglycemics; one small trial reported modest glucose-lowering. Conclusion: further high-quality studies needed before recommending bitter melon for T2DM.
前往 PubMed
The effect of bitter melon (Mormordica charantia) in patients with diabetes mellitus: a systematic review and meta-analysis.
結論：Pooled analysis showed a small reduction in fasting plasma glucose with bitter melon vs placebo but the effect on HbA1c was not statistically significant. Authors note study heterogeneity, small sample sizes, short durations, and methodological limitations. Evidence is insufficient to recommend bitter melon as a hypoglycemic agent.
前往 PubMed
Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients
結論：Bitter melon 2000 mg/day produced a modest reduction in fructosamine vs placebo but the effect was substantially smaller than metformin 1000 mg/day. Lower doses showed no significant effect. Whole-fruit form, short duration; not generalizable to peptide isolate.
前往 PubMed
L4a US FDA
謹慎
Diabalance Diabetes Supplement ... bitter melon, dandelion, bilberry and ginkgo biloba ... marketed to help balance blood sugar levels for people with diabetes ... not generally recognized as safe and effective ... and therefore constitute new drugs 來源↗
L4b EU EFSA
未表態
— 本適應症無對應資料
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
支持
本產品經動物實驗結果顯示：有助於延緩飯後血糖上升，但人體試驗結果不顯著。本產品屬保健食品，不能取代藥品。 來源↗
L4e WHO
未表態
— 本適應症無對應資料
L5a NIH Office of Dietary Supplements
謹慎
In placebo controlled clinical trials in patients with diabetes or glucose intolerance, bitter melon extracts have had only a modest effect on serum glucose levels and little or no effect on fasting plasma glucose or hemoglobin A1c levels. 來源↗
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
謹慎
Bitter melon may help lower blood sugar, but the research is mixed and the effect is modest at best. If you're already taking medication for diabetes, adding bitter melon could push your blood sugar too low. Talk to your doctor before trying it — it's not a replacement for the treatment plan you already have in place. 來源↗
L5d Harvard Health
謹慎
Many dietary supplements are marketed for diabetes, including bitter melon, chromium, and cinnamon. But there is little high-quality evidence that any of them meaningfully improve blood sugar control in people with type 2 diabetes, and some — particularly when combined with diabetes medications — can cause hypoglycemia. Food first, and talk with your doctor before adding any supplement. 來源↗
L5e Specialty Society (condition-mapped)
反對
Assess intake of supplements, as supplementation with micronutrients (e.g., vitamins and minerals, such as magnesium or chromium) or herbs or spices (e.g., cinnamon and aloe vera) is not recommended for glycemic benefits. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
台灣社群（PTT Health / regimen / Dietician 板）對苦瓜胜肽降血糖討論度中等，整體反應分歧：部分鄉民當代謝保養覺得不錯，但多有人自述吃後血糖仍微微超標、效果有限，懷疑派直指「智商稅」，營養師則強調它屬保健食品原料、無治療功效，只能輔助，飲食運動與遵醫囑才是主軸。多個帳號集中推薦特定品牌，帶中度業配色彩。社群經驗為 anecdotal，不能取代研究證據，confidence 上限 0.7。
💬社群實感
分歧（部分當代謝保養覺得有感，但多人自述血糖仍超標、效果有限，懷疑派稱智商稅；營養師定調僅能輔助）
破解迷思 社群最常見的 4 個誤解
✓
事實把苦瓜胜肽當「植物胰島素」，誤以為療效近似醫療用藥、可取代降血糖藥
✓
事實認為健康人也該預防性服用才能避免糖尿病
✓
事實誤以為單靠補充品就能控糖，忽略飲食控制與運動才是主軸
✓
事實迷信複方添加成分越多越好（實際應關注鋅、鉻等關鍵成分）
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- 大研生醫（大研苦瓜胜肽肉桂錠）
- 悠活原力
- 金大心
- 營養師輕食
- 藻衡醣
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 醫療營養治療與減重
- 規律身體活動
- Metformin（二甲雙胍）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-type2-diabetes-INT-bitter-melon-peptide-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "苦瓜胜肽（山苦瓜胜肽 / mcIRBP-19）能改善第二型糖尿病",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}